Gabriel Plotkin Laboratory Corp Of America Holdings Transaction History

Melvin Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $165 Million - $215 Million	-772,694 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $313 Million - $359 Million	-1,203,306 Reduced 60.9%	772,694 $204 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $20.6 Million - $23.9 Million	76,000 Added 4.0%	1,976,000 $621 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $13.7 Million - $15.4 Million	-50,000 Reduced 2.56%	1,900,000 $535 Million
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $113 Million - $125 Million	450,000 Added 30.0%	1,950,000 $538 Million
Q1 2021 May 17, 2021	BUY	$204.88 - $255.03 $130 Million - $162 Million	635,000 Added 73.41%	1,500,000 $383 Million
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $143 Million - $164 Million	-763,006 Reduced 46.87%	865,000 $176 Million
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $105 Million - $126 Million	628,006 Added 62.8%	1,628,006 $307 Million
Q2 2020 Aug 14, 2020	SELL	$113.31 - $182.44 $178 Million - $287 Million	-1,570,950 Reduced 61.1%	1,000,000 $166 Million
Q1 2020 May 15, 2020	BUY	$104.32 - $195.28 $114 Million - $214 Million	1,095,317 Added 74.23%	2,570,950 $325 Million
Q4 2019 Feb 14, 2020	SELL	$163.48 - $173.61 $89.1 Million - $94.6 Million	-544,844 Reduced 26.97%	1,475,633 $250 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $199 Million - $222 Million	1,245,477 Added 160.71%	2,020,477 $339 Million
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $112 Million - $134 Million	775,000 New	775,000 $134 Million

107

2.29M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Melvin Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Melvin Capital Management LP and Gabriel Plotkin with notifications on news.